Form4insider filings, from the source

SEC Form 4 · accession 0001654954-18-001717

CorMedix Inc. · CRMD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Period of report
Feb 16, 2018
Accepted (ET)
Feb 20, 2018 · 4:03 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001410098

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common Stockholding———92,052D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Stock Option (Right to Buy Common Stock)F1$0.57Feb 16, 2018A40,000A—Feb 16, 2028Common Stock40,00040,000D
Restricted Stock UnitsF2—Feb 16, 2018A10,000A——Common Stock10,00010,000D
Restricted Stock UnitsF2—Feb 16, 2018A4,000A——Common Stock4,0004,000D
Phantom StockF3—holding—————Common Stock13,39213,392D
Phantom StockF3—holding—————Common Stock15,62515,625D
Phantom StockF3—holding—————Common Stock20,83320,833D
Stock Option (Right to Buy Common Stock)F4$2.24holding————Feb 21, 2027Common Stock40,00040,000D
Restricted Stock UnitsF5—holding—————Common Stock15,35715,357D
Phantom StockF3—holding—————Common Stock3,4723,472D
Phantom StockF3—holding—————Common Stock4,1434,143D
Stock Option (Right to Buy Common Stock)F6$3.03holding————Aug 11, 2025Common Stock50,00050,000D
Phantom StockF3—holding—————Common Stock1,4151,415D
Stock Option (Right to Buy Common Stock)F7$1.91holding————Feb 21, 2026Common Stock95,00095,000D
Phantom StockF3—holding—————Common Stock3,8313,831D
Phantom StockF3—holding—————Common Stock2,7672,767D
Phantom StockF3—holding—————Common Stock4,3354,335D
Phantom StockF3—holding—————Common Stock15,30615,306D

Explanation of responses